A Study of Communication Between Clinicians, Patients, and Families in the Intensive Care Unit (ICU)
Launched by UNIVERSITY OF WISCONSIN, MADISON · Sep 15, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a multi-site observational study that will investigate the time-limited trial approach to care for patients with critical illness, which is a trial of life support with milestones and a timeline to help evaluate whether the patient is improving. The primary objective of this study is to define the optimal care delivery processes of a time-limited trial for adult intensive care unit (ICU) patients who develop acute respiratory failure requiring mechanical ventilation. The two aims of this study are to:
Aim 1: Map the current processes of time-limited trial care delivery for patients...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants
- • Adult (age ≥ 18 years)
- * Acute respiratory failure:
- • Hypoxemic (low level of oxygen in the blood) or
- • Hypercapnic (high level of carbon dioxide in the blood)
- • Receiving invasive mechanical ventilation (patient needs a breathing machine to help them breathe)
- • Surrogates
- • The main person/s (primary surrogate/s, also known as legally authorized representative/s) who are making medical decisions on behalf of an eligible patient
- • Will be identified by the treating ICU team according to established legal and ethical standards
- • ICU Team Members
- • A member of the interprofessional hospital staff that is caring for an eligible patient
- • Team members may include advanced practice providers (nurse practitioners/ physicians assistants), case managers, chaplains, dietitians, nurses, pharmacists, physical and occupational therapists, physicians (attending/fellow/resident), respiratory therapists, and social workers.
- Exclusion Criteria:
- • Participants
- • Participant or their legally authorized representative declines participation or opts-out of data collection
- • Surrogates
- • Cannot complete surveys and interviews in English or Spanish
- • Declines participation
- • ICU Team Members
- • Opts out of study participation
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Chicago, Illinois, United States
Madison, Wisconsin, United States
Philadelphia, Pennsylvania, United States
Madison, Wisconsin, United States
Madison, Wisconsin, United States
Patients applied
Trial Officials
Jacqueline M Kruser, MD, MS
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported